25th February 2026
First benchtop $100 genome system
The long-promised $100 genome may finally be entering mainstream commercial territory. Element Biosciences has launched what it describes as the first benchtop sequencing platform explicitly designed to deliver whole human genomes at that price – a step beyond earlier room-scale demonstrations by rival firms.
Read more... |